20-2311070-G-A
Variant summary
Our verdict is Likely pathogenic. Variant got 6 ACMG points: 6P and 0B. PM2PP3_Strong
The NM_003245.4(TGM3):c.481G>A(p.Gly161Ser) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000158 in 1,614,096 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003245.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TGM3 | NM_003245.4 | c.481G>A | p.Gly161Ser | missense_variant | Exon 4 of 13 | ENST00000381458.6 | NP_003236.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TGM3 | ENST00000381458.6 | c.481G>A | p.Gly161Ser | missense_variant | Exon 4 of 13 | 1 | NM_003245.4 | ENSP00000370867.5 | ||
ENSG00000286022 | ENST00000651531.1 | c.538G>A | p.Gly180Ser | missense_variant | Exon 5 of 14 | ENSP00000498584.1 |
Frequencies
GnomAD3 genomes AF: 0.000105 AC: 16AN: 152144Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000915 AC: 23AN: 251416Hom.: 0 AF XY: 0.000110 AC XY: 15AN XY: 135880
GnomAD4 exome AF: 0.000163 AC: 239AN: 1461836Hom.: 0 Cov.: 31 AF XY: 0.000157 AC XY: 114AN XY: 727216
GnomAD4 genome AF: 0.000105 AC: 16AN: 152260Hom.: 0 Cov.: 32 AF XY: 0.0000672 AC XY: 5AN XY: 74444
ClinVar
Submissions by phenotype
not specified Uncertain:1
The c.481G>A (p.G161S) alteration is located in exon 4 (coding exon 4) of the TGM3 gene. This alteration results from a G to A substitution at nucleotide position 481, causing the glycine (G) at amino acid position 161 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at